• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Sensifree Lands $5M for Contactless Biometric Monitoring Sensors

by HITC Staff 05/24/2016 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Sensifree

Sensifree, an Israeli digital health startup provider of low power, contact free, electromagnetic sensors that accurately collect a range of continuous biometric data without the need to touch the human body, today announced it has raised $5 million in Series A funding.  The round was led by TransLink Capital with participation from existing and new investors, including UMC Capital, a subsidiary of United Microelectronics Corp. and an undisclosed strategic investor.

The latest round adds to seed investment made by Samsung’s Catalyst fund and brings Sensifree’s total funding since launching its revolutionary RF-based biometric sensor technology to $7 million. Sensifree plans to utilize the funding to help the company aggressively expand its engineering and product development teams, and accelerate its business development efforts. TransLink Capital Venture Partner and Senior Advisor, Eric Hsia, will join the Sensifree Board of Directors. 

Short battery life is one of the top five reasons users stop using their wearable devices. Sensifree brings a technology breakthrough to the fast growing wearable and digital health markets, aiming to provide a better alternative to decades-old sensor technologies, with its patent pending RF-based technology.  

The Company’s first product is a contactless heart rate sensor for wearable devices for applications such as traditional watches, fitness trackers and smart clothing. Developed in partnership with Samsung’s Digital Health program, this module is integrated in Simband, Samsung’s wearable open platform for digital health apps.

Sensifree’s RF based biometric sensors and software represent a new frontier in biometric sensing technology.  Key features of Sensifree’s technology include:

· Enables the ability to monitor heart rate continuously without contact with the skin.

· Significantly lower power consumption than existing solutions, allowing continuous, high accuracy heart rate monitoring.

· Uniquely capable of working through fabrics and under water.

· Robust functionality in challenging environments- not impacted by ambient light, skin pigmentation, tattoos, hair, sweat or dirt.

· Open, extensible platform for capturing biometric data and building new software applications and services.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Israeli digital health startups, Sensifree

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

Aligning IT & Clinical Teams: How to Reduce Friction and Improve Communication

Most-Read

KLAS 2026 EHR Market Share Report: Epic Gains as Oracle Health Faces Third Year of Losses

KLAS 2026 EHR Market Share Report: Epic Gains as Oracle Health Faces Third Year of Losses

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

M&A: Qualtrics Completes $6.75B Acquisition of Press Ganey Forsta

Viz.ai Launches Viz Pulmonary™ Suite: AI-Powered Workflows for COPD, Lung Nodules, and PE

Viz.ai Launches Viz Pulmonary™ Suite: AI-Powered Workflows for COPD, Lung Nodules, and PE

PathAI Partners to Deploy First AI-Powered Biospecimen Solutions

Roche Acquires PathAI to Automate Cancer Diagnostics in $1B Deal

Vocal Biomarkers: Helping Clinicians Detect What Patients Hesitate to Share

Vocal Biomarkers: Helping Clinicians Detect What Patients Hesitate to Share

Aidoc Secures $150M to Accelerate Enterprise-Scale Clinical AI Across 2,000 Hospitals

OpenAI Launches ChatGPT for Clinicians: Free AI Documentation and Research Tool for Verified Physicians

OpenAI Launches ChatGPT for Clinicians: Free AI Documentation and Research Tool for Verified Physicians

IKS Health Acquires TruBridge for Rural EHR and RCM Solutions Expansion

IKS Health Acquires TruBridge for Rural EHR and RCM Solutions Expansion

UT Austin is Building the Nation's First 'AI-Native' Hospital, Backed by $750M

Why UT Austin is Building an ‘AI-Native’ Hospital from Scratch

The Medtech Pitch Deck Casino: Why Hype Still Wins, and How Scrutiny Could Improve Everyone’s Odds

The Casino Model: Why Medtech VCs Are Betting Billions on Unproven AI

Secondary Sidebar

Footer

Company

  • About Us
  • 2026 Editorial Calendar
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2026. HIT Consultant Media. All Rights Reserved. Privacy Policy |